Downward, Eastward or Inward? Blockbuster Film Puts Cancer Drug Prices In China Spotlight
Executive Summary
Bagging a $200m box office in its opening week in China, "Dying to Survive" is a sentimental movie about a Chinese businessman selling cancer drugs smuggled from India but unapproved in China that sees his life taking a drastic turn, from convicted felon to a Robin Hood-like hero as he helps those in need. The Chinese film authority’s clearance for the screening of the movie and the smash success signal three key messages about the future potential direction of oncology drugs in the country.
You may also be interested in...
China Releases List To Encourage Competition
China's National Health Commission issues list of 34 generic drugs that have 'insufficient' competition, seeking public comments.
Bring Them On: China Releases Generics List To Encourage Competition
China's National Health Commission issues list of 34 generic drugs that have 'insufficient' competition, seeking public comments.
Eight For 8: Things You Need To Know About China Biopharma Commercial In 2018
From AI to IPOs, from access models to mobile payments, China’s biopharma sector increasingly became a global leader in biotech financing and digital health innovation in 2018. Here is Scrip's pick of eight key events that captured the major developments in China’s dynamic, highly fluid biopharma commercial scene throughout the year.